Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naltrexone): A randomized, controlled abuse-potential study in nondependent recreational opioid users

Author:

Setnik Beatrice1,Bramson Candace2,Bass Almasa1,Levy-Cooperman Naama3,Malhotra Bimal4,Matschke Kyle5,Sommerville Kenneth W.16,Wolfram Gernot1,Geoffroy Pierre3

Affiliation:

1. Pfizer Inc; Durham NC USA

2. Pfizer Inc; Groton CT USA

3. INC Research, LLC; Toronto ON Canada

4. Pfizer Inc; New York NY USA

5. Pfizer Inc; Collegeville PA USA

6. Duke University Medical Center; Durham NC USA

Funder

Pfizer Inc.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain;Chou;J Pain.,2009

2. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm

3. http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm

4. MMWR Morb Mortal Wkly Rep 2011 60

5. Societal costs of prescription opioid abuse, dependence, and misuse in the United States;Birnbaum;Pain Med.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3